Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eli Lilly and | Svizzera | Salute | Prodotti farmaceutici | 642,13 Mrd CHF | 84,5x | 1,25 | 715 CHF | 3,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Roche Holding | Svizzera | Salute | Prodotti farmaceutici | 216,25 Mrd CHF | 19,2x | -5,89 | 272,40 CHF | 0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 5,7% Rialzo | Fai l’upgrade a Pro+ | |
Roche Holding Participation | Svizzera | Salute | Prodotti farmaceutici | 203,66 Mrd CHF | 20,4x | -5,89 | 256,60 CHF | 0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 13,9% Rialzo | Fai l’upgrade a Pro+ | |
Abbott Laboratories | Svizzera | Salute | Attrezzature e forniture medicali | 179,93 Mrd CHF | 34,6x | 2,89 | 93,50 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Novartis | Svizzera | Salute | Prodotti farmaceutici | 177,58 Mrd CHF | 11,3x | 0,13 | 88,98 CHF | 0,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Novartis | Svizzera | Salute | Prodotti farmaceutici | 177,58 Mrd CHF | 11,3x | 0,13 | 89,02 CHF | 0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 20,7% Rialzo | Fai l’upgrade a Pro+ | |
Lonza Group | Svizzera | Salute | Ricerca medica e biotecnologica | 38,60 Mrd CHF | 58x | -1,41 | 534 CHF | -0,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 18,5% Rialzo | Fai l’upgrade a Pro+ | |
Lonza Group | Svizzera | Salute | Ricerca medica e biotecnologica | 38,60 Mrd CHF | 58x | -1,41 | 534 CHF | -0,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 18,5% Rialzo | Fai l’upgrade a Pro+ | |
Alcon | Svizzera | Salute | Attrezzature e forniture medicali | 37,82 Mrd CHF | 35,8x | 0,23 | 76,38 CHF | -0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 15,8% Rialzo | Fai l’upgrade a Pro+ | |
Zimmer Biomet Holdings Inc | Svizzera | Salute | Attrezzature e forniture medicali | 18,85 Mrd CHF | 19,7x | 0,15 | 109 CHF | -3,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Straumann Holding AG | Svizzera | Salute | Attrezzature e forniture medicali | 17,95 Mrd CHF | 66,3x | -2,27 | 112,90 CHF | -1,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 19,9% Rialzo | Fai l’upgrade a Pro+ | |
Sonova Holding | Svizzera | Salute | Attrezzature e forniture medicali | 17,66 Mrd CHF | -5,31 | 228,60 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Sonova H Ag | Svizzera | Salute | Attrezzature e forniture medicali | 17,61 Mrd CHF | 31,3x | -5,31 | 296,40 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 1,2% Rialzo | Fai l’upgrade a Pro+ | |
Sandoz | Svizzera | Salute | Prodotti farmaceutici | 16,31 Mrd CHF | -2.379,2x | 22,29 | 37,54 CHF | 1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 14,7% Rialzo | Fai l’upgrade a Pro+ | |
Ypsomed Holding AG | Svizzera | Salute | Attrezzature e forniture medicali | 4,62 Mrd CHF | 62,3x | 23,65 | 338 CHF | 3,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 31,3% Rialzo | Fai l’upgrade a Pro+ | |
BACHEM HOLDING AG | Svizzera | Salute | Ricerca medica e biotecnologica | 4,43 Mrd CHF | 38,9x | 2,6 | 59 CHF | 1,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 39,9% Rialzo | Fai l’upgrade a Pro+ | |
Siegfried Holding Ltd | Svizzera | Salute | Prodotti farmaceutici | 4,24 Mrd CHF | 32,8x | -2,26 | 993 CHF | 0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 17,4% Rialzo | Fai l’upgrade a Pro+ | |
Galenica Sante | Svizzera | Salute | Prodotti farmaceutici | 3,73 Mrd CHF | 21,1x | -0,64 | 75,05 CHF | 0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 3,2% Rialzo | Fai l’upgrade a Pro+ | |
Dottikon Es Holding AG | Svizzera | Salute | Prodotti farmaceutici | 3,09 Mrd CHF | 40,9x | -3,24 | 223,50 CHF | 1,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Joincare Pharmaceutical DRC | Svizzera | Salute | Prodotti farmaceutici | 2,54 Mrd CHF | 14,7x | 4,91 | 7,22 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Lepu Medical Tech Beijing DRC | Svizzera | Salute | Attrezzature e forniture medicali | 2,46 Mrd CHF | 34,2x | -0,52 | 16,24 CHF | 12,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Medacta | Svizzera | Salute | Attrezzature e forniture medicali | 2,13 Mrd CHF | 46,2x | 3,19 | 110,20 CHF | 3,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 31,6% Rialzo | Fai l’upgrade a Pro+ | |
BB Biotech | Svizzera | Salute | Ricerca medica e biotecnologica | 2 Mrd CHF | 15,9x | 0,11 | 36,65 CHF | 3,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
BB Biotech | Svizzera | Salute | Ricerca medica e biotecnologica | 1,94 Mrd CHF | 15,9x | 0,11 | 34,95 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
SKAN | Svizzera | Salute | Attrezzature e forniture medicali | 1,71 Mrd CHF | 55,9x | 3,04 | 77,20 CHF | 1,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 20,7% Rialzo | Fai l’upgrade a Pro+ | |
Aevis Victoria | Svizzera | Salute | Fornitori e servizi sanitari | 1,20 Mrd CHF | -41x | 0,02 | 14,10 CHF | -5,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
COSMO Pharma | Svizzera | Salute | Prodotti farmaceutici | 1,03 Mrd CHF | 15,8x | 0,03 | 64,20 CHF | 0,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 39,6% Rialzo | Fai l’upgrade a Pro+ | |
PolyPeptide Group AG | Svizzera | Salute | Prodotti farmaceutici | 936,73 Mln CHF | -35x | -1,63 | 29,25 CHF | 3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 17,6% Rialzo | Fai l’upgrade a Pro+ | |
Kuros Biosciences | Svizzera | Salute | Ricerca medica e biotecnologica | 809,70 Mln CHF | -70,5x | -2,98 | 21,50 CHF | 0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Medartis | Svizzera | Salute | Attrezzature e forniture medicali | 777,66 Mln CHF | 183,3x | 1,28 | 57,70 CHF | 1,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |